InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: RetiredPharma post# 225

Thursday, 12/29/2016 4:33:44 PM

Thursday, December 29, 2016 4:33:44 PM

Post# of 449
I have read and replied to your opinions on SA and have been impressed. This must have shocked you. I agree that the liver issue appears to be overblown.

They will not have that kind of money banked by next year. I am sure you listened to the call today and it is shocking that they did not mention any cost reducing measures.

MFG is an easy fix. I shouldn't have bought again especially after she was fired. I wish my friend traded it, he was the one who originally told me to absolutely not trust that CEO, and then he was snookered to the tune of multiple 7 figures.

He has been the head of B/D and held other top positions at major Pharma's, and he trusted the data and her presentations.

You think a trial can be done in 12 months, here is where we disagree. They do not even know if the they need to recruit 9000 or 18,000 subjects. I don't think it will be as easy as you think, but I hope I am wrong. The FDA doesn't trust them.

And if it is successful the labeling and second line assignment will stunt sales. I stopped trusting them when they decided to roll out their own sales force.